Prof. dr. Toon van Gorp voor Belg van het jaar
Prof. dr. Toon van Gorp is genomineerd voor Belg van het jaar. Zijn bijdrage aan baanbrekend onderzoek naar eierstokkanker bracht hem in het lijstje van 100 straffe Belgen.
Leuven Gynaecological Oncology Group
Shaping the future treatments for our patients
We're here to help with your therapy
LGOG, the Leuven Gynaecological Oncology Group, originated from the department of gynaecological oncology at the University Hospital Leuven.
Our department specialises in the diagnosis and treatment of gynaecological cancers. These include cancers of the ovaries, fallopian tubes, peritoneum, uterus, cervix and placenta.
Useful information
Additional information concerning the different services of our department can be found below.
Participation in a clinical trial
Here you can find information regarding clinical trials and your possible participation in one
Message board
New treatment successfull in therapy-resistant ovarian cancer
An international trial, led by UZ Leuven, shows that ovarian cancer patients treated with an antibody combined with chemotherapy have a longer survival compared to patients treated with standard…
Genetic test determines maintenance treatment for ovarian cancer
Researchers in Leuven develop a genetic test to determine in which patients a maintenance treatment with PARP inhibitors would be effective
Therapy resistance in ovarian cancer unraveled
Ovarian cancer can usually be treated effectively with platin-based treatments, but over time nearly all patients do relapse because the tumour cells become resistant. A preclinical trial led by UZ…
Founding Member of
the Belgium and Luxembourg Gynaecologic Oncology Group (BGOG) & the European Network of Gynaecologic Oncological Trial Groups (ENGOT)
